Spectral AI, Inc. (MDAI)
| Market Cap | 30.21M |
| Revenue (ttm) | 18.06M |
| Net Income (ttm) | -20.85M |
| Shares Out | 17.56M |
| EPS (ttm) | -1.48 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 261,732 |
| Open | 1.760 |
| Previous Close | 1.780 |
| Day's Range | 1.680 - 1.770 |
| 52-Week Range | 1.680 - 19.500 |
| Beta | 0.57 |
| Analysts | Strong Buy |
| Price Target | 4.00 (+132.56%) |
| Earnings Date | May 7, 2024 |
About MDAI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinici... [Read more]
Financial Performance
In 2023, Spectral AI's revenue was $18.06 million, a decrease of -28.82% compared to the previous year's $25.37 million. Losses were -$20.85 million, 616.1% more than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for MDAI stock is "Strong Buy" and the 12-month stock price forecast is $4.0.
News
Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center
DALLAS, April 30, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders Spangenberg brings significant IP monetization experience and the po...
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Experienced Burn Industry Executive Champions Pivot to Commercialization Experienced Burn Industry Executive Champions Pivot to Commercialization
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024
Spectral AI Secures Access to $12.5 Million of New Equity Capital
Issuance of Convertible Instrument Balances Certainty, Timing, and Execution Capital Supports Strategic Imperatives and Commercialization Initiatives
Spectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence Ecosystem
DALLAS, March 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
In the past six months, the Company has announced over $149 million of non-dilutive financing from the US Government for the DeepView™ Wound Imaging System In the past six months, the Company has anno...
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
DALLAS, March 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Appoints Peter M. Carlson as CEO
Appointment Paves the Way for Company's Next Chapter in Commercialization Phase of AI-Powered DeepView Device for Predictive Wound Care
Spectral AI to Participate in Upcoming Investor Conferences
DALLAS, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
DALLAS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company ”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more...
Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors
The Company's two largest stockholders holding approximately 45% of the Company's outstanding shares have extended their lock-up agreements for an additional 180 days The Company's two largest stockho...
Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
DALLAS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Announces Publication of Letter to Shareholders
DALLAS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral Submits Application for UKCA Mark Classification
DALLAS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Spectral MD, Inc. (“SMD”), a subsidiary of Spectral AI, Inc. (NASD: MDAI; MDAIW) (“Spectral AI” or the “Company ”), an artificial intelligence (AI) company fo...
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries
DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more acc...
Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO
DALLAS, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI to Participate in Benchmark's 12th Annual Discovery One-on-One Conference
DALLAS, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster an...
Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors
DALLAS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Announces 2023 Third Quarter Financial Results
Highlights Continuing Progress in Developing and Commercializing AI-Driven DeepView ® System Wound Healing Assessment Technology
Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call
DALLAS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA
DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Provides 2023-2024 Annual Revenue Guidance
Highlights Path Forward and Opportunities Associated with AI-Driven DeepView® Wound Imaging Technology Highlights Path Forward and Opportunities Associated with AI-Driven DeepView® Wound Imaging Techn...